Ecto-enzymes of lymphoid cells

Immunological Reviews

Volumn 161, Issue , 1998, Pages 5-10

  Goding, James W ^a   Howard, Maureen C ^b  

^a ALFRED HOSPITAL   (Australia)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALKALINE PHOSPHATASE; CELL ENZYME; DIPEPTIDYL PEPTIDASE; GLUTAMYL AMINOPEPTIDASE; MEMBRANE ENZYME; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; PEPTIDASE;

ANIMAL CELL; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031908460     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01567.x     Document Type: Review

References (39)

1. Stanley KK, Newby AC, Luzio JP. What do ectoenzymes do? Trends Biochem Sci 1982;7:145-147.
2. Naquet P, Pierres M. Cell-surface enzymes and lymphocyte functions. Curr Opin Immunol 1991;3:326-329.
3. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 1993;82:1052-1070.
4. Kenny AJ, Turner AJ. What are ecto-enzymes? In: Kenny AJ, ed. Mammalian Ecto-Enzymes. New York: Elsevier;1987.p.1-13.
5. Wang J, Lin Q, Wu Q, Cooper MD. The enigmatic role of glutamyl aminopeptidase (BP-1/6C3 antigen) in immune system development. Immunol Rev 1998;161:71-77.
6. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. Ecto-phosphodiesterase/ pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 1998;161:11-26.
7. Deterre P, et al. Co-ordinated regulation of CD38 and other nucleotide hydrolyzing ecto-enzymatic activities in human T-cells. J Immunol 1996;157:1381-1388.
8. Enari M, Sakahira H, Yokayama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
9. Wylie A. An endonuclease at last. Nature 1998;391:20-21.
10. Burnstock G. Physiological and pathological roles of purines: an update. Drug Development Research 1993;28: 195-206.
11. Burnstock G. P2 purinoceptors: historical perspective and classification. P2 purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Found Symp 1995;198:1-28.
12. Burnstock G. Introduction - purinergic transmission. Semin Neurosci 1996;8:171-174.
13. Weisman GA, Turner JT, Fedan JS. Structure and function of P2 purinoceptors. J Pharmacol Exp Ther 1996;277:1-9.
14. Zimmerman H. Signalling via ATP in the nervous system. Trends Neurosci 1994;17:420-426.
15. Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol 1995;158:141-214.
16. Plesner L, Kirley TL, Knowles AF. Ecto-ATPases. Recent progress on structure and function. New York: Plenum Press;1996.
17. Dombrowski KE, Ke Y. Brewer KA, Kapp JA. Ecto-ATPase: an activation marker necessary for effector cell function. Immunol Rev 1998;161:111-118.
18. Snyder SH. Knockouts anxious for new therapy. Nature 1997;388:624.
19. + glycohydrolase. Biochem J 1998 (In press).
20. +-converting enzymes. Extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol 1997;159:3858-3865.
21. Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, Howard MC CD38: a new paradigm in lymphocyte activation and signal transduction. Immunol Rev 1998;161:79-93.
22. Konkoy CS, Davis TP. Ectoenzymes as sites of peptide regulation. Trends Pharmacol Sci 1996;17:288-294.
23. Krause SW, Rehli M, Andreesen R. Carboxypeptidase M as a marker of macrophage maturation. Immunol Rev 1998;161:119-127.
24. Weber M, Uguccioni M, Baggiolini M, Clarke-Lewis I, Dahinden C. Deletion of the NH2-terminal residue converts Monocyte Chemotactic Protein I from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 1996;183:681-685.
25. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-585.
26. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994;331:250-258.
27. von Bonin A, Hühn J, Fleischer B. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol Rev 1998;161:43-53.
28. Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev 1998;161:55-70.
29. Deaglio S, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998 (In press).
30. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998;161:95-109.
31. Franco R. Valenzuela A, Lluis C, Blanco J. Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol Rev 1998;161:27-42.
32. Lub M, van Kooyk Y, Figdor CG. Ins and outs of LFA-1. Immunol Today 1995;16:479-483.
33. Petty HR, Toddy RF. Integrins as promiscuous signal transduction devices. Immunol Today 1996;17:209-211.
34. 3 avidity. J Biol Chem 1997;272:28757-28761.
35. + glycohydrolase CD38 exhibit altered humoral immune responses. Blood 1998 (In press).
36. Thatcher JW, Shaw JM, Dickinson WJ. Marginal fitness contributions of nonessential genes in yeast. Proc Natl Acad Sci USA 1998;95:253-257.
37. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996;94:563-574.
38. Hilton DJ. Leukaemia inhibitory factor (LIF). In: Nicola NA, ed. Guidebook to Cytokines and Their Receptors. Oxford: Oxford University Press; 1994.p.124-126.
39. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. The Leucocyte Antigen Facts Book. San Diego: Academic Press;1997.p.112-114.